

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 8.89765220 |
| 2 | cytidine catabolic process (GO:0006216) | 8.89765220 |
| 3 | cytidine deamination (GO:0009972) | 8.89765220 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.85753769 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.00877974 |
| 6 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.23780784 |
| 7 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.03937488 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.93774678 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.91771343 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 3.91771343 |
| 11 | actin nucleation (GO:0045010) | 3.86466265 |
| 12 | positive thymic T cell selection (GO:0045059) | 3.72087987 |
| 13 | negative T cell selection (GO:0043383) | 3.68581308 |
| 14 | positive T cell selection (GO:0043368) | 3.68214538 |
| 15 | behavioral response to nicotine (GO:0035095) | 3.65962303 |
| 16 | positive regulation of prostaglandin secretion (GO:0032308) | 3.56474930 |
| 17 | proteasome assembly (GO:0043248) | 3.55381740 |
| 18 | protein neddylation (GO:0045116) | 3.53031395 |
| 19 | ribosomal small subunit assembly (GO:0000028) | 3.49656381 |
| 20 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.46893662 |
| 21 | positive regulation of defense response to virus by host (GO:0002230) | 3.40633347 |
| 22 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.34662698 |
| 23 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.34038331 |
| 24 | negative regulation of T cell apoptotic process (GO:0070233) | 3.33505631 |
| 25 | regulation of regulatory T cell differentiation (GO:0045589) | 3.29692921 |
| 26 | negative regulation of viral genome replication (GO:0045071) | 3.27839352 |
| 27 | sequestering of actin monomers (GO:0042989) | 3.24863592 |
| 28 | T cell migration (GO:0072678) | 3.24318520 |
| 29 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.24228504 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.23019569 |
| 31 | positive regulation of fatty acid transport (GO:2000193) | 3.20872722 |
| 32 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.20192964 |
| 33 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.20192964 |
| 34 | negative regulation of mast cell activation (GO:0033004) | 3.19292116 |
| 35 | cellular response to interleukin-15 (GO:0071350) | 3.18817960 |
| 36 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.18778498 |
| 37 | positive regulation of tolerance induction (GO:0002645) | 3.14560558 |
| 38 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.14530479 |
| 39 | negative regulation by host of viral transcription (GO:0043922) | 3.14063752 |
| 40 | DNA demethylation (GO:0080111) | 3.13137105 |
| 41 | respiratory electron transport chain (GO:0022904) | 3.10535003 |
| 42 | electron transport chain (GO:0022900) | 3.09325435 |
| 43 | maturation of SSU-rRNA (GO:0030490) | 3.09104648 |
| 44 | negative thymic T cell selection (GO:0045060) | 3.07526247 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06420740 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06371731 |
| 47 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.05463979 |
| 48 | positive regulation of protein homodimerization activity (GO:0090073) | 3.05081136 |
| 49 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.99155809 |
| 50 | protein-cofactor linkage (GO:0018065) | 2.97766083 |
| 51 | regulation of chronic inflammatory response (GO:0002676) | 2.96017752 |
| 52 | platelet dense granule organization (GO:0060155) | 2.95421120 |
| 53 | negative regulation of telomere maintenance (GO:0032205) | 2.94587711 |
| 54 | positive regulation of cell killing (GO:0031343) | 2.90144392 |
| 55 | regulation of activation of Janus kinase activity (GO:0010533) | 2.88740263 |
| 56 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.85988242 |
| 57 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.85718615 |
| 58 | thymic T cell selection (GO:0045061) | 2.84055826 |
| 59 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.81810551 |
| 60 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.81650238 |
| 61 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.81568564 |
| 62 | positive regulation of icosanoid secretion (GO:0032305) | 2.80512371 |
| 63 | regulation of prostaglandin secretion (GO:0032306) | 2.80207486 |
| 64 | chaperone-mediated protein transport (GO:0072321) | 2.79840533 |
| 65 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79555361 |
| 66 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79555361 |
| 67 | cytolysis (GO:0019835) | 2.77838303 |
| 68 | response to interferon-beta (GO:0035456) | 2.77645516 |
| 69 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.77592592 |
| 70 | negative regulation of B cell apoptotic process (GO:0002903) | 2.76481355 |
| 71 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.76283283 |
| 72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.75631485 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.74301846 |
| 74 | rRNA modification (GO:0000154) | 2.72301970 |
| 75 | DNA dealkylation (GO:0035510) | 2.71699766 |
| 76 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71531101 |
| 77 | T cell receptor signaling pathway (GO:0050852) | 2.71265332 |
| 78 | metallo-sulfur cluster assembly (GO:0031163) | 2.69206609 |
| 79 | iron-sulfur cluster assembly (GO:0016226) | 2.69206609 |
| 80 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.66497131 |
| 81 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.64932105 |
| 82 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.63642308 |
| 83 | regulation of T cell chemotaxis (GO:0010819) | 2.63177082 |
| 84 | positive regulation of T cell chemotaxis (GO:0010820) | 2.63177082 |
| 85 | regulation of cell killing (GO:0031341) | 2.62728462 |
| 86 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.61592052 |
| 87 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.61592052 |
| 88 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.61592052 |
| 89 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.61262609 |
| 90 | protein complex biogenesis (GO:0070271) | 2.60653963 |
| 91 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.59460955 |
| 92 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.59460955 |
| 93 | S-adenosylmethionine metabolic process (GO:0046500) | 2.57555410 |
| 94 | mast cell activation (GO:0045576) | 2.57242259 |
| 95 | mast cell activation involved in immune response (GO:0002279) | 2.57200343 |
| 96 | mast cell degranulation (GO:0043303) | 2.57200343 |
| 97 | sulfation (GO:0051923) | 2.57155036 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55622744 |
| 99 | ubiquinone biosynthetic process (GO:0006744) | 2.53242451 |
| 100 | DNA deamination (GO:0045006) | 10.0050396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84473980 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.36526419 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.34993898 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.31581935 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.98145833 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.91934558 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86857287 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72467964 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.63805292 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.61987801 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.51428687 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.47607860 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.46176587 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.39913467 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.39441326 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.35711535 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19549169 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07847531 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06708556 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99048102 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98219754 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94293386 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93810299 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.91660810 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89706143 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87810461 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80794512 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69165257 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.64338299 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63095341 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.62747163 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.62287284 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61180039 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54252779 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52638739 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.52247930 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51543121 |
| 38 | NCOR_22424771_ChIP-Seq_293T_Human | 1.49948367 |
| 39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47632462 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46162668 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44658025 |
| 42 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.40611022 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39470264 |
| 44 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35483595 |
| 45 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35482822 |
| 46 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.33541320 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29978586 |
| 48 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28562718 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28494548 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27986371 |
| 51 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26241863 |
| 52 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.25253334 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21983205 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21870719 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21507274 |
| 56 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.20387719 |
| 57 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.19367253 |
| 58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17839291 |
| 59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15426907 |
| 60 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.14065861 |
| 61 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12976786 |
| 62 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12857635 |
| 63 | ERA_21632823_ChIP-Seq_H3396_Human | 1.11695323 |
| 64 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11372622 |
| 65 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11372622 |
| 66 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09728747 |
| 67 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09034258 |
| 68 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09034258 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08072980 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05371039 |
| 71 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04359973 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04019194 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02343715 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01413864 |
| 75 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.99980962 |
| 76 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.98391850 |
| 77 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98334019 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97642653 |
| 79 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.96839139 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96746950 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96746950 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96102232 |
| 83 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94876158 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94727227 |
| 85 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94712824 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94501425 |
| 87 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94113372 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94095279 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93334776 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92363290 |
| 91 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90441820 |
| 92 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.90302729 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 0.89838787 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89779852 |
| 95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89645904 |
| 96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89005928 |
| 97 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87879142 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.87566156 |
| 99 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.87133823 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85743041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.76158082 |
| 2 | MP0004147_increased_porphyrin_level | 3.22776282 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.78067029 |
| 4 | MP0003646_muscle_fatigue | 2.77771407 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.68057670 |
| 6 | MP0000685_abnormal_immune_system | 2.66348501 |
| 7 | MP0009785_altered_susceptibility_to | 2.57741997 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.08977231 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.04744616 |
| 10 | MP0001873_stomach_inflammation | 2.02304543 |
| 11 | MP0005000_abnormal_immune_tolerance | 1.97394736 |
| 12 | MP0003786_premature_aging | 1.95444909 |
| 13 | MP0001188_hyperpigmentation | 1.88390558 |
| 14 | MP0000569_abnormal_digit_pigmentation | 1.86636127 |
| 15 | MP0001800_abnormal_humoral_immune | 1.85031945 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 1.83249534 |
| 17 | MP0003866_abnormal_defecation | 1.81374541 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 1.79067420 |
| 19 | MP0001905_abnormal_dopamine_level | 1.79059710 |
| 20 | MP0002420_abnormal_adaptive_immunity | 1.75955827 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.72981932 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.70433354 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 1.70417493 |
| 24 | MP0008872_abnormal_physiological_respon | 1.70069149 |
| 25 | MP0002736_abnormal_nociception_after | 1.69317816 |
| 26 | MP0001819_abnormal_immune_cell | 1.68675271 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.68523649 |
| 28 | MP0001661_extended_life_span | 1.68395442 |
| 29 | MP0002723_abnormal_immune_serum | 1.67270675 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.66636950 |
| 31 | MP0005025_abnormal_response_to | 1.61632714 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.61593138 |
| 33 | MP0002822_catalepsy | 1.60015404 |
| 34 | MP0005387_immune_system_phenotype | 1.58712665 |
| 35 | MP0001790_abnormal_immune_system | 1.58712665 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.57580844 |
| 37 | MP0004885_abnormal_endolymph | 1.53952322 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.53765499 |
| 39 | MP0002006_tumorigenesis | 1.52708233 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.50986225 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.50701947 |
| 42 | MP0003195_calcinosis | 1.49285860 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.49021024 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.44627365 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.39847474 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.39391523 |
| 47 | MP0001919_abnormal_reproductive_system | 1.35753798 |
| 48 | MP0003880_abnormal_central_pattern | 1.35069468 |
| 49 | MP0000716_abnormal_immune_system | 1.34813647 |
| 50 | MP0002398_abnormal_bone_marrow | 1.34546361 |
| 51 | MP0006082_CNS_inflammation | 1.34473573 |
| 52 | MP0008995_early_reproductive_senescence | 1.33826534 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29513515 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.26909467 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.26563063 |
| 56 | MP0005389_reproductive_system_phenotype | 1.25367476 |
| 57 | MP0001542_abnormal_bone_strength | 1.24819338 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.24446285 |
| 59 | MP0002405_respiratory_system_inflammati | 1.23839469 |
| 60 | MP0004142_abnormal_muscle_tone | 1.22498497 |
| 61 | MP0009745_abnormal_behavioral_response | 1.21882954 |
| 62 | MP0009764_decreased_sensitivity_to | 1.20946921 |
| 63 | MP0002722_abnormal_immune_system | 1.19404798 |
| 64 | MP0000372_irregular_coat_pigmentation | 1.18990832 |
| 65 | MP0009046_muscle_twitch | 1.18925436 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.17254320 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.15812916 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.15714872 |
| 69 | MP0002272_abnormal_nervous_system | 1.13933013 |
| 70 | MP0003011_delayed_dark_adaptation | 1.12320214 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.08297776 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.04690856 |
| 73 | MP0002163_abnormal_gland_morphology | 1.04324328 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.03440045 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.98290070 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.97483250 |
| 77 | MP0005253_abnormal_eye_physiology | 0.97066369 |
| 78 | MP0002429_abnormal_blood_cell | 0.96888201 |
| 79 | MP0002102_abnormal_ear_morphology | 0.94474732 |
| 80 | MP0002733_abnormal_thermal_nociception | 0.93095260 |
| 81 | MP0001970_abnormal_pain_threshold | 0.85962317 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.85707462 |
| 83 | MP0004043_abnormal_pH_regulation | 0.82332776 |
| 84 | MP0003436_decreased_susceptibility_to | 0.80956102 |
| 85 | MP0002160_abnormal_reproductive_system | 0.76509944 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 0.75493403 |
| 87 | MP0002419_abnormal_innate_immunity | 0.74684623 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.74404680 |
| 89 | MP0000613_abnormal_salivary_gland | 0.74210930 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.72869450 |
| 91 | MP0008469_abnormal_protein_level | 0.72308654 |
| 92 | MP0005423_abnormal_somatic_nervous | 0.72238618 |
| 93 | MP0005646_abnormal_pituitary_gland | 0.71249524 |
| 94 | MP0008873_increased_physiological_sensi | 0.70609515 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.69642459 |
| 96 | MP0001663_abnormal_digestive_system | 0.65926992 |
| 97 | MP0003448_altered_tumor_morphology | 0.65524216 |
| 98 | MP0001529_abnormal_vocalization | 0.64577049 |
| 99 | MP0005360_urolithiasis | 0.64334512 |
| 100 | MP0005410_abnormal_fertilization | 0.63257633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.24057217 |
| 2 | Severe combined immunodeficiency (HP:0004430) | 3.90121376 |
| 3 | Pancreatic cysts (HP:0001737) | 3.82578118 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.75234050 |
| 5 | Aplastic anemia (HP:0001915) | 3.71399110 |
| 6 | Pancreatic fibrosis (HP:0100732) | 3.66304111 |
| 7 | T lymphocytopenia (HP:0005403) | 3.60088140 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.58225515 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.57421542 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.41601099 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.37460192 |
| 12 | Thyroiditis (HP:0100646) | 3.32683272 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.30665183 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.29344243 |
| 15 | Increased CSF lactate (HP:0002490) | 3.28413247 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 3.27292565 |
| 17 | Abnormality of eosinophils (HP:0001879) | 3.26507917 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.24241445 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.24241445 |
| 20 | Increased IgM level (HP:0003496) | 3.16396915 |
| 21 | Hepatic necrosis (HP:0002605) | 3.13819498 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10486439 |
| 23 | Congenital stationary night blindness (HP:0007642) | 3.06090428 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 2.97895674 |
| 25 | Congenital, generalized hypertrichosis (HP:0004540) | 2.97113763 |
| 26 | Combined immunodeficiency (HP:0005387) | 2.96041969 |
| 27 | True hermaphroditism (HP:0010459) | 2.89315980 |
| 28 | Abnormality of B cell number (HP:0010975) | 2.87997520 |
| 29 | Hypoproteinemia (HP:0003075) | 2.87318206 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.82550157 |
| 31 | Increased muscle lipid content (HP:0009058) | 2.80736780 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78390233 |
| 33 | Acute encephalopathy (HP:0006846) | 2.72422324 |
| 34 | Progressive macrocephaly (HP:0004481) | 2.68664263 |
| 35 | Eosinophilia (HP:0001880) | 2.65467476 |
| 36 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.60092356 |
| 37 | Abnormality of T cells (HP:0002843) | 2.58747936 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57620654 |
| 39 | Abnormality of the prostate (HP:0008775) | 2.56959110 |
| 40 | Increased serum lactate (HP:0002151) | 2.54884581 |
| 41 | Type 2 muscle fiber atrophy (HP:0003554) | 2.45853678 |
| 42 | Abnormality of the renal cortex (HP:0011035) | 2.40726422 |
| 43 | B lymphocytopenia (HP:0010976) | 2.39759077 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.38653480 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.34163325 |
| 46 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.32153813 |
| 47 | Cerebral edema (HP:0002181) | 2.30331847 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.27625686 |
| 49 | Pancytopenia (HP:0001876) | 2.25752229 |
| 50 | Optic disc pallor (HP:0000543) | 2.24293279 |
| 51 | Renal cortical cysts (HP:0000803) | 2.23481690 |
| 52 | Exertional dyspnea (HP:0002875) | 2.18614448 |
| 53 | Cystic liver disease (HP:0006706) | 2.18448570 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18116184 |
| 55 | Hypoplasia of the pons (HP:0012110) | 2.15569539 |
| 56 | Muscle fiber atrophy (HP:0100295) | 2.14634175 |
| 57 | Stomatitis (HP:0010280) | 2.12159536 |
| 58 | Polydipsia (HP:0001959) | 2.11512846 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.11512846 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10241979 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10241979 |
| 62 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08220929 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08220929 |
| 64 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.07771467 |
| 65 | Lactic acidosis (HP:0003128) | 2.06813040 |
| 66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04974043 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.04974043 |
| 68 | Hyperalaninemia (HP:0003348) | 2.04974043 |
| 69 | Polyuria (HP:0000103) | 2.04672655 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.03875296 |
| 71 | Prostate neoplasm (HP:0100787) | 2.01505637 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 1.98048528 |
| 73 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97194870 |
| 74 | Abnormality of the pons (HP:0007361) | 1.97156507 |
| 75 | Chorioretinal atrophy (HP:0000533) | 1.96647512 |
| 76 | Sclerocornea (HP:0000647) | 1.95780645 |
| 77 | Hypoplasia of the thymus (HP:0000778) | 1.95307734 |
| 78 | Constricted visual fields (HP:0001133) | 1.95068204 |
| 79 | Absent thumb (HP:0009777) | 1.94088701 |
| 80 | Abnormality of renal resorption (HP:0011038) | 1.93217877 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 1.93125072 |
| 82 | Glycosuria (HP:0003076) | 1.93125072 |
| 83 | Medial flaring of the eyebrow (HP:0010747) | 1.90617017 |
| 84 | Encephalitis (HP:0002383) | 1.89964780 |
| 85 | Nephronophthisis (HP:0000090) | 1.88601594 |
| 86 | Leukocytosis (HP:0001974) | 1.88516302 |
| 87 | Abnormal number of erythroid precursors (HP:0012131) | 1.87888492 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87073561 |
| 89 | Hypomagnesemia (HP:0002917) | 1.86447282 |
| 90 | Pendular nystagmus (HP:0012043) | 1.84959327 |
| 91 | Recurrent bronchitis (HP:0002837) | 1.83866442 |
| 92 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83712112 |
| 93 | Granulocytopenia (HP:0001913) | 1.83228738 |
| 94 | Hemiplegia (HP:0002301) | 1.79691754 |
| 95 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.79540751 |
| 96 | Decreased central vision (HP:0007663) | 1.78194729 |
| 97 | Asplenia (HP:0001746) | 1.77799596 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 1.76556494 |
| 99 | Abnormality of magnesium homeostasis (HP:0004921) | 1.76492009 |
| 100 | Agammaglobulinemia (HP:0004432) | 1.74124089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.46238616 |
| 2 | TXK | 3.43980391 |
| 3 | TESK2 | 3.17015931 |
| 4 | TLK1 | 3.04653854 |
| 5 | BCKDK | 3.02938568 |
| 6 | ZAK | 2.97596297 |
| 7 | VRK2 | 2.51495928 |
| 8 | TAOK3 | 2.37314188 |
| 9 | GRK1 | 2.23096823 |
| 10 | LIMK1 | 2.16199302 |
| 11 | MUSK | 2.09575271 |
| 12 | ADRBK2 | 1.98976620 |
| 13 | ITK | 1.88527943 |
| 14 | MAP4K1 | 1.87927831 |
| 15 | KIT | 1.76102760 |
| 16 | FRK | 1.74550416 |
| 17 | GRK6 | 1.66198199 |
| 18 | NUAK1 | 1.65585935 |
| 19 | VRK1 | 1.57888205 |
| 20 | SYK | 1.57701950 |
| 21 | WNK4 | 1.56210599 |
| 22 | PLK2 | 1.53916496 |
| 23 | FES | 1.53286415 |
| 24 | MAPKAPK3 | 1.49686668 |
| 25 | EIF2AK3 | 1.42661128 |
| 26 | TAF1 | 1.40717226 |
| 27 | TESK1 | 1.29455775 |
| 28 | BUB1 | 1.28685165 |
| 29 | NME1 | 1.24556461 |
| 30 | BMPR1B | 1.20331627 |
| 31 | MAP3K12 | 1.18208427 |
| 32 | CAMKK2 | 1.16463676 |
| 33 | PRKCQ | 1.13156802 |
| 34 | LCK | 1.08268789 |
| 35 | IKBKB | 1.07992525 |
| 36 | PIM2 | 1.06263047 |
| 37 | BTK | 1.05504777 |
| 38 | MAP3K11 | 1.05362855 |
| 39 | TIE1 | 1.04600052 |
| 40 | MAP4K2 | 1.02993406 |
| 41 | ZAP70 | 1.02102086 |
| 42 | NTRK2 | 1.00258068 |
| 43 | TEC | 0.99962895 |
| 44 | PHKG2 | 0.96080802 |
| 45 | PHKG1 | 0.96080802 |
| 46 | MST4 | 0.95222042 |
| 47 | MAPK13 | 0.92387103 |
| 48 | OXSR1 | 0.90001666 |
| 49 | LYN | 0.81241197 |
| 50 | CSK | 0.79308949 |
| 51 | IKBKE | 0.74172167 |
| 52 | WNK3 | 0.73714316 |
| 53 | INSRR | 0.72669945 |
| 54 | MAPKAPK5 | 0.68440166 |
| 55 | MAP2K7 | 0.68368082 |
| 56 | DYRK2 | 0.67844400 |
| 57 | PASK | 0.66932061 |
| 58 | RPS6KA5 | 0.65155828 |
| 59 | CAMKK1 | 0.64873540 |
| 60 | SCYL2 | 0.64650883 |
| 61 | STK16 | 0.64051565 |
| 62 | CSNK1G3 | 0.62637266 |
| 63 | DAPK1 | 0.60342730 |
| 64 | PRKCI | 0.59543059 |
| 65 | ADRBK1 | 0.59071838 |
| 66 | NTRK1 | 0.58864446 |
| 67 | CSF1R | 0.56470755 |
| 68 | CSNK1G2 | 0.56469952 |
| 69 | OBSCN | 0.49972453 |
| 70 | IGF1R | 0.49239675 |
| 71 | PINK1 | 0.48631292 |
| 72 | CAMK2A | 0.47292413 |
| 73 | MYLK | 0.46626462 |
| 74 | ATR | 0.45962605 |
| 75 | NTRK3 | 0.45778288 |
| 76 | PRKD3 | 0.45712181 |
| 77 | NEK1 | 0.45408214 |
| 78 | TSSK6 | 0.44912863 |
| 79 | DAPK2 | 0.44893608 |
| 80 | PRKCA | 0.44628468 |
| 81 | PIM1 | 0.42312082 |
| 82 | PRKACA | 0.41967979 |
| 83 | SRPK1 | 0.41743856 |
| 84 | PRKCE | 0.41296921 |
| 85 | CSNK1G1 | 0.38383863 |
| 86 | PRKCH | 0.37564069 |
| 87 | JAK3 | 0.36978165 |
| 88 | DAPK3 | 0.35160585 |
| 89 | CSNK1A1L | 0.34564863 |
| 90 | ACVR1B | 0.34341575 |
| 91 | EPHB2 | 0.34097960 |
| 92 | GRK7 | 0.32038658 |
| 93 | MATK | 0.31426717 |
| 94 | HCK | 0.31354178 |
| 95 | PRKCD | 0.30786356 |
| 96 | CSNK2A1 | 0.29949261 |
| 97 | GRK5 | 0.29448275 |
| 98 | PLK3 | 0.28940089 |
| 99 | PIK3CA | 0.27932113 |
| 100 | TNK2 | 0.27615824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.55152675 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.92748865 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.55876321 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.15199638 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.81680171 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.60938799 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.57653353 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.30336627 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.29219384 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25367160 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17514120 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.14803942 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12586369 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.01930922 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.95011357 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.90818901 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90732872 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83586583 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.83260833 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.77828694 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.76320607 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70186771 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.57418052 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56681970 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.43924260 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40607951 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39807808 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39314947 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35151374 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.30723687 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29416174 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21438195 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21365917 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19548348 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17938281 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.11115978 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10399044 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06520640 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03799913 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00374524 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 0.94569015 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93274390 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91737234 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89899420 |
| 45 | Purine metabolism_Homo sapiens_hsa00230 | 0.89184042 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88328315 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84655829 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83095691 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82169743 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82134665 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80902388 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.73419409 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71786116 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68553193 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.67049208 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65771357 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.64882894 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63954633 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.62898945 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61472126 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60480467 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.59970655 |
| 63 | Mismatch repair_Homo sapiens_hsa03430 | 0.59126249 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.58092147 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.55206300 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54922689 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54604524 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51852513 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51610638 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51305418 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51227948 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50452897 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.48416587 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.47767686 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46931505 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45613874 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43877664 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43411537 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41738259 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40901474 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40080520 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38994801 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38926860 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37788299 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36998393 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33904933 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33709346 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32660890 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30613271 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.29269004 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28310894 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27254808 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.25915032 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.25653836 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24822128 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24443842 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.23510535 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19869755 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.19613279 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.16568039 |

